January 6, 2015 Patient-Reported Outcomes In Cancer Drug Development And US Regulatory Review: Perspectives From Industry, The Food And Drug Administration, And The Patient
February 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development Provides major boost for improved development of TB treatment to meet major public health challenge TUCSON, Ariz., February 6, 201
January 12, 2014 Regulatory Science Needs for Neonates: A Call for Neonatal Community Collaboration and Innovation
January 12, 2014 Modeling And Simulation For Medical Product Development And Evaluation: Highlights From The FDA-C-Path-ISOP 2013 Workshop
November 17, 2014 Dr. Brumfield’s Remarks at Partnering for Cures Dr. Martha Brumfield, C-Path’s President and CEO, participated in a panel discussion on November 17, 2014, “Playing ni
